Zhejiang Hisoar Pharmaceutical Co., Ltd.

SZSE:002099.SZ

6.76 (CNY) • At close October 26, 2023
Overview | Financials

Numbers are in millions (except for per share data and ratios) CNY.

202320222021202020192018201720162015201420132012201120102009200820072006200520042003
Revenue 2,171.8872,704.1442,484.8282,471.3872,941.4132,718.6092,308.9222,433.8622,464.4961,319.1361,160.6911,145.3741,298.4381,074.589893.3691,062.9961,034.886770.206690.764506.101373.748
Cost of Revenue 1,867.2441,983.871,559.3921,348.8071,463.1591,511.9451,317.3951,368.3181,325.174908.316946.482920.877986.601791.94726.198924.262894.59633.246552.743412.073306.682
Gross Profit 304.642720.274925.4371,122.5791,478.2531,206.664991.5271,065.5441,139.322410.82214.209224.497311.837282.65167.171138.734140.296136.96138.02194.02767.066
Gross Profit Ratio 0.140.2660.3720.4540.5030.4440.4290.4380.4620.3110.1850.1960.240.2630.1870.1310.1360.1780.20.1860.179
Reseach & Development Expenses 115.565148.495167.772134.721124.483113.072108.31113.842120.59786.82256.60244.26446.9243.8130000000
General & Administrative Expenses 101.36299.73498.675109.30786.53673.68466.57176.81470.45435.48239.38237.04132.6823.84495.81169.35254.7433.68540.66126.95225.265
Selling & Marketing Expenses 29.21926.28126.71924.86759.62343.78139.27537.94136.3723.91417.21316.94716.92618.34813.07312.70412.2069.677.6546.945.281
SG&A 130.581126.015125.394134.174146.159117.465105.846114.756106.82459.39556.59553.98849.60642.192108.88382.05666.94643.35548.31433.89330.546
Other Expenses -34.005295.504477.469389.476297.419-8.547-4.8219.70112.0744.72810.06122.7437.3064.9051.9360.4130.7663.499-2.406-1.2571.091
Operating Expenses 471.007570.014770.636658.371568.061524.761480.581555.254522.152286.906218.792184.116172.665156.984112.67884.64771.11446.07650.13133.94630.563
Operating Income -464.243240.39122.045395.266918.821710.852399.675327.263613.16661.343-102.7143.325120.88399.83134.03529.75647.73574.06277.32951.58832.663
Operating Income Ratio -0.2140.0890.0490.160.3120.2610.1730.1340.2490.047-0.0880.0030.0930.0930.0380.0280.0460.0960.1120.1020.087
Total Other Income Expenses Net -1.98-139.5870.989-1.759-6.36815.393-111.082-175.5777.071-58.648-93.485-15.784-12.282-25.332-20.19-24.398-20.681-18.538-15.687-10.692-4.178
Income Before Tax -466.223100.803123.034393.507912.453697.296399.864334.713624.24165.266-98.06824.597126.889100.33434.30429.68948.50174.95373.56349.86133.039
Income Before Tax Ratio -0.2150.0370.050.1590.310.2560.1730.1380.2530.049-0.0840.0210.0980.0930.0380.0280.0470.0970.1060.0990.088
Income Tax Expense -44.64214.72529.16673.808141.67192.29257.507110.15114.74520.6081.1984.37322.84414.4653.9644.217.06422.17323.19914.16310.175
Net Income -420.05688.01495.23319.715770.782605.004342.217225.018516.58753.519-82.10722.78105.06485.62830.30225.59731.05152.11349.59635.13422.421
Net Income Ratio -0.1930.0330.0380.1290.2620.2230.1480.0920.210.041-0.0710.020.0810.080.0340.0240.030.0680.0720.0690.06
EPS -0.260.0540.0590.20.480.380.220.150.360.07-0.130.0350.170.130.0480.040.0480.110.10.0730.12
EPS Diluted -0.260.0540.0590.20.480.380.210.150.360.07-0.120.0350.170.130.0480.040.0480.110.10.0730.12
EBITDA 221.615576.909455.039675.6891,145.056950.47637.589638.501842.412243.49478.741122.342195.89173.896105.34294.23799.976112.507101.91474.18446.122
EBITDA Ratio 0.1020.2130.1830.2730.3890.350.2760.2620.3420.1850.0680.1070.1510.1620.1180.0890.0970.1460.1480.1470.123